J103-0273 Screening compound: N-{1-[(3,4-dimethoxyphenyl)methyl]piperidin-4-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide

J103-0273 Screening compound: N-{1-[(3,4-dimethoxyphenyl)methyl]piperidin-4-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide
J103-0273 Screening compound: N-{1-[(3,4-dimethoxyphenyl)methyl]piperidin-4-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J103-0273
N-{1-[(3,4-dimethoxyphenyl)methyl]piperidin-4-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J103-0273

Molecular Formula

C24H32N4O4 (C24 H32 N4 O4)

Compound Name

N-{1-[(3,4-dimethoxyphenyl)methyl]piperidin-4-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide

IUPAC name

N-{1-[(34-dimethoxyphenyl)methyl]piperidin-4-yl}-2-(3-oxo-235678-hexahydrocinnolin-2-yl)acetamide

SMILES

COc(ccc(CN(CC1)CCC1NC(CN1N=C(CCCC2)C2=CC1=O)=O)c1)c1OC

InChI

InChI=1S/C24H32N4O4/c1-31-21-8-7-17(13-22(21)32-2)15-27-11-9-19(10-12-27)25-23(29)16-28-24(30)14-18-5-3-4-6-20(18)26-28/h7-8,13-14,19H,3-6,9-12,15-16H2,1-2H3,(H,25,29)

InChI Key

MFFBEBZVQRZDCD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27962884

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.408

Distribution Coefficient, logD

-1.325

Water Solubility, LogSw

-2.32

Polar Surface Area

71.231

Acid Dissociation Constant (pKa)

16.71

Base Dissociation Constant (pKb)

10.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

J103-0273 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Antibacterial Compounds Library (13827 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Immune system
  • animal
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with J103-0273 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J103-0273?
Check Price and Availability of J103-0273, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J103-0273 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J103-0273
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J103-0273
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J103-0273 available by request